Table 7.

Clinical Outcomes for Tracheostomy Patient Subpopulation by Overall Serum-Associated Antibiotic Tolerance (SAT) Status and SAT Pharmacologic Phenotype

Outcome	SAT-Negative (n = 4)	SAT-Positive (n = 10)	P Value	Minocycline SAT-Positive (n = 7)	P Value	Tobramycin SAT-Positive (n = 5)	P Value
Duration with fever, median (IQR), d	1.0 (0.5, 4.0)	0.0 (0.0, 0.0)	.21	0.0 (0.0, 0.0)	.21	0.0 (0.0, 1.0)	.63
Duration in pediatric intensive care unit, median (IQR), d	1.0 (0.0, 2.0)	0.5 (0.0, 3.0)	.83	0.0 (0.0, 3.0)	.82	1.0 (0.0, 19.0)	.73
Hospital length of stay, median (IQR), d	6.0 (4.5, 39.0)	5.5 (3.0, 11.0)	.73	6.0 (5.0, 11.0)	.94	11.0 (2.0, 18.0)	.90
Duration of antibiotics, median (IQR), d	6.0 (4.0, 8.0)	3.0 (0.0, 9.0)	.56	3.0 (3.0, 9.0)	.74	9.0 (3.0, 10.0)	.72
Duration of oxygen therapy (>home requirement), median (IQR), d	6.5 (4.5, 10.0)	6.0 (4.0, 9.0)	1.0	6.0 (6.0, 9.0)	.85	9.0 (3.0, 11.0)	1.0
Mortality, n (%)	0 (0.0)	1 (10.0)	1.0	1 (11.1)	1.0	1 (20)	1.0

Abbreviation: IQR, interquartile range; SAT, serum-associated antibiotic tolerance.